| 書目名稱 | Hereditary Retinopathies | | 副標題 | Progress in Developm | | 編輯 | Pete Humphries,Marian M. Humphries,Anna-Sophia Kia | | 視頻video | http://file.papertrans.cn/426/425847/425847.mp4 | | 概述 | Provides a snap-shot of current gene and drug-based therapies for hereditary retinal disorders.The authors explore emerging topics such as novel gene or drug delivery methods to the retina and retinal | | 叢書名稱 | SpringerBriefs in Genetics | | 圖書封面 |  | | 描述 | The hereditary retinopathy, retinitis pigmentosa (RP), which affects 1 in 3,500 people worldwide, is the most common cause of registered visual handicap among those of the working age in developed countries. RP is a highly variable disorder where patients may develop symptomatic visual loss in early childhood, while others may remain asymptomatic until mid-adulthood. Most cases of RP segregate in autosomal dominant, recessive or X-linked recessive modes, with approximately 41 genes being implicated in disease pathology to date (RetNet). The extensive genetic heterogeneity associated with autosomal dominant RP (adRP) is an undisputed hindrance to the development of genetically based therapeutics. | | 出版日期 | Book 2012 | | 關鍵詞 | gene therapy | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-4614-4499-2 | | isbn_softcover | 978-1-4614-4498-5 | | isbn_ebook | 978-1-4614-4499-2Series ISSN 2191-5563 Series E-ISSN 2191-5571 | | issn_series | 2191-5563 | | copyright | The Author(s) 2012 |
The information of publication is updating
|
|
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網安備110108008328)
GMT+8, 2025-10-13 04:25
發(fā)表于 2025-3-21 16:34:37
發(fā)表于 2025-3-21 21:36:10
